Toms River-based clinical research site network CenExel has appointed Dr. Arun Singh as the primary principal investigator for its Toms River site.
Singh will lead clinical trial execution and oversee all aspects of clinical trial leadership, including patient safety, quality of care, protocol execution, site operations, and collaboration with sponsors and study teams.
CenExel Toms River is the largest Alzheimer’s disease clinical research site in the Northeast. It has a strong reputation for advancing research in memory disorders and related neurological conditions.
This appointment supports the firm’s continued investment in creating centers of excellence, particularly in expanding research access and strengthening its presence in New Jersey, according to a release.
Singh joined the former Advanced Memory Research Institute in September 2019 as a sub-Principal Investigator, conducting clinical research on Alzheimer’s Disease. He graduated from Rutgers University and attended medical school at Rowan Medical School.
He also currently works as a board-certified Emergency Medicine physician at Ocean Medical Center in Brick.
